Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Researchers at Saitama University have discovered that a tiny single-domain antibody (VHH6) can recognize the folded 3D structure of a DNA aptamer — and binds over 4x more strongly when an antibiotic is present. The finding flips the script on conventional aptamer research and could pave the way for novel biosensors capable of detecting small molecules like antibiotic residues in food. It's a step toward teaching antibodies to "read" DNA shapes, not just protein targets.
Scientists have long used DNA aptamers — short, folded DNA molecules — to detect proteins and small chemicals. But researchers at Saitama University flipped the concept on its head: instead of DNA recognizing a target, they asked whether an antibody could recognize the folded structure of DNA itself. The answer, it turns out, is yes.
Using a combination of cDNA display screening, surface plasmon resonance, and AI-powered structural prediction (AlphaFold3), the team identified a VHH antibody called VHH6 that binds to a DNA aptamer associated with oxytetracycline (OTC), a common veterinary antibiotic. Crucially, VHH6's binding behavior shifts depending on whether OTC is present — suggesting the antibody is sensitive to structural changes in the aptamer triggered by its target molecule. The findings were published in Antibodies.
By the Numbers:
Why it matters: Detecting antibiotic residues in food, monitoring environmental contaminants, and advancing molecular diagnostics all require tools that can sense small molecules with high precision. This research lays a conceptual and technical foundation for biosensors that combine the target-binding power of DNA aptamers with the structural recognition of antibodies — potentially filling a major gap in current detection technologies.